Literature DB >> 10213019

Screening inpatient quality using post-discharge events.

L I Iezzoni1, Y D Mackiernan, M J Cahalane, R S Phillips, R B Davis, K Miller.   

Abstract

BACKGROUND: Decreasing hospital lengths of stay (LOS) hamper efforts to detect and to definitively treat complications of care. Patients leave before some complications are identified.
OBJECTIVES: To develop a computerized method to screen for hospital complications using readily available administrative data from outpatient and nonacute care within 90 days of discharge.
DESIGN: We developed the Complications Screening Program for Outpatient data (CSP-O) by using diagnosis and procedure codes from Medicare Part A and B claims to define 50 complication screens. Seventeen apply to specific procedural cases, and 33 apply to all adult, acute, medical, or surgical hospitalizations. The CSP-O algorithm examined outpatient, physician office, home health agency, and hospice claims within 90 days following discharge.
SUBJECTS: Seven hundred thirty nine thousand, two hundred and forty eight discharges of Medicare beneficiaries (age range, > or = 65 years) were admitted to 515 hospitals nationwide in 1994.
RESULTS: Complete 90-day, post-discharge windows were present for 62.8% of all and 68.5% of procedural cases. The 33 general screens flagged 13.6% of all cases; only 1.8% of procedural cases were flagged by the 17 procedural screens. When we allowed the CSP-O algorithm to scan information from acute hospital readmissions, flag rates rose to 32.8% for general and 8.7% for procedural complications. Controlling for patient and hospital characteristics, flag rates were considerably higher among the very old and at small and for-profit institutions.
CONCLUSIONS: Whereas several CSP-O findings have construct validity, limitations of claims raise concerns. Regardless of the CSPO's ultimate utility, examining post-discharge experiences to identify inpatient complications remains important as LOSs fall.

Entities:  

Mesh:

Year:  1999        PMID: 10213019     DOI: 10.1097/00005650-199904000-00008

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  6 in total

Review 1.  A systematic review and meta-analysis of studies comparing mortality rates of private for-profit and private not-for-profit hospitals.

Authors:  P J Devereaux; Peter T L Choi; Christina Lacchetti; Bruce Weaver; Holger J Schünemann; Ted Haines; John N Lavis; Brydon J B Grant; David R S Haslam; Mohit Bhandari; Terrence Sullivan; Deborah J Cook; Stephen D Walter; Maureen Meade; Humaira Khan; Neera Bhatnagar; Gordon H Guyatt
Journal:  CMAJ       Date:  2002-05-28       Impact factor: 8.262

2.  Understanding the relationship between the Centers for Medicare and Medicaid Services' Hospital Compare star rating, surgical case volume, and short-term outcomes after major cancer surgery.

Authors:  Deborah R Kaye; Edward C Norton; Chad Ellimoottil; Zaojun Ye; James M Dupree; Lindsey A Herrel; David C Miller
Journal:  Cancer       Date:  2017-06-30       Impact factor: 6.860

3.  Association Between Patient Satisfaction and Short-Term Outcomes After Major Cancer Surgery.

Authors:  Deborah R Kaye; Caroline R Richardson; Zaojun Ye; Lindsey A Herrel; Chad Ellimoottil; David C Miller
Journal:  Ann Surg Oncol       Date:  2017-08-17       Impact factor: 5.344

4.  Association of Delivery System Integration and Outcomes for Major Cancer Surgery.

Authors:  Jonathan Li; Zaojun Ye; James M Dupree; Brent K Hollenbeck; Hye Sung Min; Deborah Kaye; Lindsey A Herrel; David C Miller; Chad Ellimoottil
Journal:  Ann Surg Oncol       Date:  2017-12-29       Impact factor: 5.344

5.  Postdischarge adverse drug reactions in primary care originating from hospital care in France: a nationwide prospective study.

Authors:  L Letrilliart; T Hanslik; M Biour; J P Fagot; M Guiguet; A Flahault
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

6.  Early impact of Medicare accountable care organizations on cancer surgery outcomes.

Authors:  Lindsey A Herrel; Edward C Norton; Scott R Hawken; Zaojun Ye; Brent K Hollenbeck; David C Miller
Journal:  Cancer       Date:  2016-05-24       Impact factor: 6.860

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.